R

Repare Therapeutics

RPTX

3.41000
USD
-0.33
(-8.82%)
Market Closed
Volume
481
EPS
0
Div Yield
0
P/E
-2
Market Cap
148,983,821
Related Instruments
B
BEAM
-1.310
(-4.14%)
30.330 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
N
NTLA
-1.100
(-4.19%)
25.130 USD
News

Title: Repare Therapeutics

Sector: Healthcare
Industry: Biotechnology
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.